Ketorolac Supplier-Buyer Network — Trade Flow Analysis

Name: Ketorolac Supplier-Buyer Trade Network Dataset — 351+ Indian Exporters, 18+ Importers, 124+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Ketorolac supplier network, Ketorolac buyers, pharmaceutical export India, Ketorolac trade data

TransData Nexus

Ketorolac

India Pharmaceutical Trade Intelligence

$115.9M351 Suppliers124 CountriesHS 30049067

ExportsIndia → UNITED STATES63.1%India → RUSSIA23.4%

ImportsUNITED STATES → India$722.1K UNITED KINGDOM → India$13.4K

#1 Supplier: GLAND PHARMA #1 Buyer: EVERSANA LIFE

Who Supplies Ketorolac? Top Manufacturers & Buyers 2026 — GLAND PHARMA LIMITED Leads | TransData Nexus | TransData Nexus

1GLAND PHARMA LTD

GLAND PHARMA LTD is the first-largest Ketorolac exporter from India, with a market share of 13.6% and a total export value of $15.7M across 193 shipments. Their average shipment value of $81.4K is above the market average of $39.1K, suggesting premium or bulk contract pricing.

GLAND PHARMA LTD serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 85.3% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES LLC — $13.4M across 165 shipments (85.3% of this supplier's total exports)

• JUNO PHARMACEUTICALS CORP — $874.4K across 11 shipments (5.6% of this supplier's total exports)

• BOSTON ONCOLOGY ARAB — $549.8K across 7 shipments (3.5% of this supplier's total exports)

• JUNO PHARMACEUTICALS CORP — $453.7K across 6 shipments (2.9% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES LLC — $424.4K across 5 shipments (2.7% of this supplier's total exports)

Key Insight: GLAND PHARMA LTD's per-shipment value of $81.4K is 108% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.

2GLAND PHARMA LIMITED

GLAND PHARMA LIMITED is the second-largest Ketorolac exporter from India, with a market share of 11.0% and a total export value of $12.7M across 212 shipments. Their average shipment value of $59.9K is above the market average of $39.1K, suggesting premium or bulk contract pricing.

GLAND PHARMA LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 64.3% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES LLC — $8.2M across 136 shipments (64.3% of this supplier's total exports)

• EVERSANA EVERSANA — $2.6M across 43 shipments (20.4% of this supplier's total exports)

• EVERSANA — $783.0K across 13 shipments (6.2% of this supplier's total exports)

• JUNO PHARMACEUTICALS CORP — $780.8K across 13 shipments (6.2% of this supplier's total exports)

• ALMAJECT — $382.5K across 6 shipments (3.0% of this supplier's total exports)

Key Insight: GLAND PHARMA LIMITED's per-shipment value of $59.9K is 53% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.

3ALEMBIC PHARMACEUTICALS LIMITED

ALEMBIC PHARMACEUTICALS LIMITED is the third-largest Ketorolac exporter from India, with a market share of 10.3% and a total export value of $12.0M across 70 shipments. Their average shipment value of $170.9K is above the market average of $39.1K, suggesting premium or bulk contract pricing.

ALEMBIC PHARMACEUTICALS LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• J KNIPPER COMPANY — $5.3M across 31 shipments (44.7% of this supplier's total exports)

• J KNIPPER COMPANY — $3.1M across 18 shipments (26.2% of this supplier's total exports)

• J KNIPPER COMPANY — $2.6M across 15 shipments (22.0% of this supplier's total exports)

• J. KNIPPER & COMPANY. — $853.5K across 5 shipments (7.1% of this supplier's total exports)

Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $170.9K is 337% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.

4CAPLIN STERILES LIMITED

CAPLIN STERILES LIMITED is the fourth-largest Ketorolac exporter from India, with a market share of 7.8% and a total export value of $9.1M across 230 shipments. Their average shipment value of $39.5K is above the market average of $39.1K, suggesting premium or bulk contract pricing.

CAPLIN STERILES LIMITED serves 5 named buyers in our database. BAXTER HEALTHCARE CORPORATION is the dominant customer, accounting for 55.2% of this supplier's tracked business. Top customers include:

• BAXTER HEALTHCARE CORPORATION — $5.0M across 127 shipments (55.2% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER — $2.1M across 53 shipments (22.9% of this supplier's total exports)

• SOLA PHARMACEUTICALS — $1.2M across 31 shipments (13.3% of this supplier's total exports)

• GLEANMARK PHARMCEUTI — $415.2K across 11 shipments (4.6% of this supplier's total exports)

• GLENMARK PHARMACEUTI — $364.6K across 9 shipments (4.0% of this supplier's total exports)

Key Insight: CAPLIN STERILES LIMITED's per-shipment value of $39.5K is 1% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.

5SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Ketorolac exporter from India, with a market share of 7.7% and a total export value of $8.9M across 95 shipments. Their average shipment value of $94.0K is above the market average of $39.1K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 3 named buyers in our database. AO RANBAXY is the dominant customer, accounting for 70.3% of this supplier's tracked business. Top customers include:

• AO RANBAXY — $6.3M across 67 shipments (70.3% of this supplier's total exports)

• AO RANBAXY — $2.7M across 28 shipments (29.7% of this supplier's total exports)

• REPRESENTATIVE OFFIC — $24 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $94.0K is 140% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.

6MICRO LABS LIMITED

MICRO LABS LIMITED is the fifth-largest Ketorolac exporter from India, with a market share of 3.0% and a total export value of $3.5M across 60 shipments. Their average shipment value of $58.0K is above the market average of $39.1K, suggesting premium or bulk contract pricing.

MICRO LABS LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 69.9% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES LLC — $2.4M across 42 shipments (69.9% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES LLC — $653.5K across 11 shipments (18.8% of this supplier's total exports)

• MICRO LABS GMBH — $181.4K across 3 shipments (5.2% of this supplier's total exports)

• MSK PHARMALOGISTIC G — $135.6K across 2 shipments (3.9% of this supplier's total exports)

• BROWN AND BURK UK LI — $75.8K across 1 shipments (2.2% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED's per-shipment value of $58.0K is 48% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Ketorolac imports from India, with a total trade value of $73.2M across 613 shipments — representing a 63.1% share of all Ketorolac exports. The average shipment value of $119.3K is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations. This market is served by 15 tracked buyers.

Named Ketorolac importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 35.5% ($26.0M) of this market's total imports.

• EVERSANA LIFE SCIENCE SERVICES — $26.0M (35.5% of United States's total)

• BAXTER HEALTHCARE CORPORATION — $6.6M (9.0% of United States's total)

• J KNIPPER COMPANY — $5.5M (7.6% of United States's total)

Key Insight: United States's per-shipment average of $119.3K (205% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Ketorolac imports from India.

Primary Market

Secondary Market

2Russia

Russia ranks as the second-largest destination for Ketorolac imports from India, with a total trade value of $27.1M across 90 shipments — representing a 23.4% share of all Ketorolac exports. The average shipment value of $301.1K is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Ketorolac importers in Russia: AO "RANBAXY" is the largest buyer, accounting for 67.4% ($18.3M) of this market's total imports.

• AO "RANBAXY" — $18.3M (67.4% of Russia's total)

• AO RANBAXY — $6.7M (24.7% of Russia's total)

Key Insight: Russia's per-shipment average of $301.1K (670% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Ketorolac imports from India.

Primary Market

Secondary Market

3Canada

Canada ranks as the third-largest destination for Ketorolac imports from India, with a total trade value of $3.1M across 36 shipments — representing a 2.7% share of all Ketorolac exports. The average shipment value of $86.9K is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ketorolac importers in Canada: JUNO PHARMACEUTICALS CORP is the largest buyer, accounting for 54.4% ($1.7M) of this market's total imports.

• JUNO PHARMACEUTICALS CORP — $1.7M (54.4% of Canada's total)

Key Insight: Canada's per-shipment average of $86.9K (122% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Ketorolac imports from India.

Primary Market

Secondary Market

4Ecuador

Ecuador ranks as the fourth-largest destination for Ketorolac imports from India, with a total trade value of $2.3M across 32 shipments — representing a 2.0% share of all Ketorolac exports. The average shipment value of $71.0K is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ketorolac importers in Ecuador: DYVENPRO DISTRIBUCION Y VENTA DE is the largest buyer, accounting for 48.7% ($1.1M) of this market's total imports.

• DYVENPRO DISTRIBUCION Y VENTA DE — $1.1M (48.7% of Ecuador's total)

Key Insight: Ecuador's per-shipment average of $71.0K (81% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ecuador is a key market for Ketorolac imports from India.

Primary Market

Secondary Market

5United Arab Emirates

United Arab Emirates ranks as the fifth-largest destination for Ketorolac imports from India, with a total trade value of $1.0M across 0 shipments — representing a 0.9% share of all Ketorolac exports. The average shipment value of $1.0M is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations.

Key Insight: United Arab Emirates's per-shipment average of $1.0M (2547% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Arab Emirates is a key market for Ketorolac imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ketorolac.
2.Flow Mapping: 351 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,961 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 124 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,961 Verified Shipments

351 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Ketorolac

Ketorolac

Who Supplies Ketorolac? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Ketorolac — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Ketorolac? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Ketorolac Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1GLAND PHARMA LTD

2GLAND PHARMA LIMITED

3ALEMBIC PHARMACEUTICALS LIMITED

4CAPLIN STERILES LIMITED

5SUN PHARMACEUTICAL INDUSTRIES LIMITED

6MICRO LABS LIMITED

From Indian Factories to Global Pharmacies — How Ketorolac Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Ketorolac Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Russia

3Canada

4Ecuador

5United Arab Emirates

People Also Ask — Ketorolac Supplier & Trade Network

Ketorolac Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology